China Pharma Events Attract Record Attendance

AMSTERDAM, June 24, 2010 - Leading events organiser UBM International Media and sister company UBM
Sinexpo today announced that a record attendance of 26,547 at its 2010
Chinese Pharma events cluster — CPhI China for intermediates and APIs; P-MEC
for equipment and machinery; plus trails for ICSE Contract Services; and
BioPh for the biopharma sector — representing an increase of 12.3% over 2009
attendance levels. The collocated events, which took place from June 2-4 at
the Shanghai New International Expo Centre, are the largest annual networking
event for the Asian pharmaceutical community and this year saw an increase of
13% in international visitors over 2009.

Exhibitor figures were also surpassed at the 2010 events, attracting
1,391 exhibitors at CPhI China and 330 at P-MEC China, from a total of 18
countries. On-site space bookings for the 2011 events, scheduled for 21-23
June 2011, again at Shanghai New International Expo Centre, are at record
levels, with both existing and new exhibitors signing up in line with rapidly
accelerating market growth.

"The continued growth of our China events is testament to the strength of
the Chinese pharma market, which is projected to be the third largest pharma
market globally by 2011 and second largest by 2020," commented Eliane van
Doorn, UBM International Media's Group Director for Pharma Events. "We have
witnessed significant growth in the number of Western visitors year-on-year,
and the fact that we saw an increase of 13% at this year's events is a
reflection of changes within the industry, such as those to local GMP
standards, which make sourcing in China increasingly appealing. Factors such
as these simply add to the attraction of the many outsourcing and production
efficiency partnering opportunities for which China is already globally
renowned. This growing demand for outsourcing of contract services has led us
to introduce a dedicated ICSE pavilion for the 2011 event."

In addition to the exhibition and networking elements, CPhI China offered
over 25 seminars and presentations, many of which were fully booked, and
focused on dynamic changes in the Chinese pharmaceutical market and US
Quality Standards. Highlights included keynote speakers from Roche, Hovione,
Wuxi AppTec and the FDA while a panel discussion carried out a SWOT analysis
of the current outsourcing market in China.

Now in its tenth year, CPhI China was joined by ICSE China in 2005, P-MEC
China in 2006 and BioPh China in 2010. The events benefit from the support of
the China Chamber of Commerce for Import and Export of Medicines and Health
Products (CCCMHPIE) and are organised in conjunction with UBM International
Media's sister organisation, UBM Sinexpo. For further information on CPhI
China and P-MEC China see: www.cphi-china.com and
www.pmec-china.com.

    Notes for Editors:
    -- UBM International Media operates market-leading global exhibition
       brands and their complementary media products.

    -- The CPhI pharmaceutical ingredients and related sector exhibitions
       currently number over 15 highly-regarded annual events. The portfolio
       also includes Informex (specialty chemicals), Food Ingredients, HBA
       (health & beauty industry) and Sea Trade (cruise industry).

    -- Worldwide locations for its events include China, India, Japan, North
       America, Brazil, Africa and Europe. More than 330,000 business
       professionals and marketers visit UBM exhibitions each year. The
       exhibitions portfolio is managed from Holland. UBM International Media
       has approximately 1,200 employees in the UK, US, Asia and Europe. See
       www.ubm.com

Media Enquiries: Impress PR, Global (excl. North America): Richard Kerns, +44-161-728-5880, richard at impress-pr.com, North America: Mark Button, +1-503-616-3817, mark at impress-pr.com, Company Enquiries: UBM International Media, Rob Sahi (CPhI), +31-20-40-99-5561, or Ian O'Malley (ICSE, P-MEC, BioPharma), +31-20-40-99-5526